Company news

OPKO Health, Inc. news in 2020

OPKO Health, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program

December 30, 2020

OPKO Health Appoints Dr. Roger Medel to its Board of Directors

December 20, 2020

OPKO Health to Participate in Three Upcoming Investment Conferences

November 10, 2020

OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results

October 28, 2020

OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test

October 19, 2020

OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020

October 12, 2020

OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools

October 8, 2020

OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients

September 14, 2020

OPKO Health to Participate in Two September Investment Conferences

September 1, 2020

OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

September 1, 2020

OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay

August 31, 2020

OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services

August 11, 2020

OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio

August 5, 2020

OPKO Health to Participate in BTIG Virtual Biotechnology Conference

August 4, 2020

OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results

July 29, 2020

OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020

July 26, 2020

OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)

July 19, 2020

OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees

July 12, 2020

Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees

July 8, 2020

OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency

June 8, 2020

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients

May 31, 2020

OPKO Health to Present at the Jefferies Virtual Healthcare Conference

May 26, 2020

OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results

May 5, 2020

OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020

April 29, 2020

Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020

April 21, 2020

OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies

March 24, 2020

OPKO Health Reports 2019 Fourth Quarter Business Highlights and Financial Results

February 25, 2020

OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020

February 19, 2020

Calls in 2020

Decks in 2020